Discontinuation of low-dose acetylsalicylic acid therapy in UK primary care: incidence and predictors in patients with cardiovascular disease

References

• GrahamIAtarDBorch-JohnsenKfor European Society of Cardiology (ESC)European Association for Cardiovascular Prevention and Rehabilitation (EACPR)Council on Cardiovascular NursingEuropean Association for Study of Diabetes (EASD)International Diabetes Federation Europe (IDF-Europe)European Stroke Initiative (EUSI)International Society of Behavioural Medicine (ISBM)European Society of Hypertension (ESH)European Society of General Practice/Family Medicine (ESGP/FM/WONCA)European Heart Network (EHN)European guidelines on cardiovascular disease prevention in clinical practice: executive summaryEur Heart J200728192375241417726041
   PubMed Web of Science ®Google Scholar
• Antithrombotic Trialists’ (ATT) CollaborationAspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trialsLancet20093731849186019482214
   PubMed Web of Science ®Google Scholar
• MaulazABBezerraDCMichelPBogousslavskyJEffect of discontinuing aspirin therapy on the risk of brain ischemic strokeArch Neurol20056281217122016087761
   PubMedGoogle Scholar
• FerrariEBenhamouMCerboniPMarcelBCoronary syndromes following aspirin withdrawal: a special risk for late stent thrombosisJ Am Coll Cardiol200545345645915680728
   PubMed Web of Science ®Google Scholar
• Biondi-ZoccaiGGLotrionteMAgostoniPA systematic review and meta-analysis on the hazards of discontinuing or not adhering to aspirin among 50,279 patients at risk for coronary artery diseaseEur Heart J200627222667267417053008
   PubMed Web of Science ®Google Scholar
• LordkipanidzeMDiodatiJGPharandCPossibility of a rebound phenomenon following antiplatelet therapy withdrawal: a look at the clinical and pharmacological evidencePharmacol Ther2009123217818619426760
   PubMed Web of Science ®Google Scholar
• De SchryverELvan GijnJKappelleLJKoudstaalPJAlgraAfor Dutch TIA Trial and SPIRIT study groupsNon-adherence to aspirin or oral anticoagulants in secondary prevention after ischaemic strokeJ Neurol2005252111316132115868068
   PubMed Web of Science ®Google Scholar
• NewbyLKBhapkarMVWhiteHDfor SYMPHONY and 2nd SYMPHONY InvestigatorsAspirin use post-acute coronary syndromes: intolerance, bleeding and discontinuationJ Thromb Thrombolysis200316311912815087598
   PubMed Web of Science ®Google Scholar
• HerlitzJTothPPNaesdalJLow-dose aspirin therapy for cardiovascular prevention: quantification and consequences of poor compliance or discontinuationAm J Cardiovasc Drugs201010212514120334450
   PubMed Web of Science ®Google Scholar
• García RodríguezLAHernández-DíazSde AbajoFJAssociation between aspirin and upper gastrointestinal complications: systematic review of epidemiologic studiesBr J Clin Pharmacol200152556357111736865
   PubMed Web of Science ®Google Scholar
• ColletJPMontalescotGBlanchetBImpact of prior use or recent withdrawal of oral antiplatelet agents on acute coronary syndromesCirculation2004110162361236715477397
   PubMed Web of Science ®Google Scholar
• YeomansNLanasALabenzJEfficacy of esomeprazole (20 mg once daily) for reducing the risk of gastroduodenal ulcers associated with continuous use of low-dose aspirinAm J Gastroenterol2008103102465247318637091
   PubMed Web of Science ®Google Scholar
• ScheimanJMDevereauxPJHerlitzJPrevention of peptic ulcers with esomeprazole in patients at risk for ulcer development treated with low-dose acetylsalicylic acid: a randomised, controlled trial (OBERON)Heart2011971079780221415072
   PubMed Web of Science ®Google Scholar
• LinKJHernandez-DiazSRodriguezLAAcid suppressants reduce risk of gastrointestinal bleeding in patients on antithrombotic or anti-inflammatory therapyGastroenterology2011141717921458456
   PubMed Web of Science ®Google Scholar
• HaydenMPignoneMPhillipsCMulrowCAspirin for the primary prevention of cardiovascular events: a summary of the evidence for the U.S. Preventive Services Task ForceAnn Intern Med2002136216117211790072
   PubMed Web of Science ®Google Scholar
• BourkeADattaniHRobinsonMFeasibility study and methodology to create a quality-evaluated database of primary care dataInform Prim Care200412317117715606990
   PubMedGoogle Scholar
• García RodríguezLALinKJHernández-DíazSJohanssonSRisk of upper gastrointestinal bleeding with low-dose acetylsalicylic acid alone and in combination with clopidogrel and other medicationsCirculation20111231108111521357821
   PubMed Web of Science ®Google Scholar
• LewisJDSchinnarRBilkerWBWangXStromBLValidation studies of the health improvement network (THIN) database for pharmacoepidemiology researchPharmacoepidemiol Drug Saf200716439340117066486
   PubMed Web of Science ®Google Scholar
• MorrisRCarstairsVWhich deprivation? A comparison of selected deprivation indexesJ Public Health Med19911343183261764290
   PubMedGoogle Scholar
• García RodríguezLACea-SorianoLMartin-MerinoEJohanssenSDiscontinuation of low dose aspirin and risk of myocardial infarction: case-control study in UK primary careBMJ2011343d409421771831
   PubMed Web of Science ®Google Scholar
• García RodríguezLACea SorianoLHillCJohanssenSIncreased risk of stroke after discontinuation of acetylsalicylic acid: a UK primary care studyNeurology201176874074621270415
   PubMed Web of Science ®Google Scholar
• LanzaFLChanFKQuigleyEMfor Practice Parameters Committee of the American College of GastroenterologyGuidelines for prevention of NSAID-related ulcer complicationsAm J Gastroenterol2009104372873819240698
   PubMed Web of Science ®Google Scholar
• AbrahamNSHlatkyMAAntmanEMfor ACCF/ACG/AHAACCF/ACG/AHA 2010 Expert Consensus Document on the concomitant use of proton pump inhibitors and thienopyridines: a focused update of the ACCF/ACG/AHA 2008 expert consensus document on reducing the gastrointestinal risks of antiplatelet therapy and NSAID use: a report of the American College of Cardiology Foundation Task Force on Expert Consensus DocumentsCirculation2010122242619263321060077
   PubMed Web of Science ®Google Scholar
• YangYXMetzDCSafety of proton pump inhibitor exposureGastroenterology201013941115112720727892
   PubMed Web of Science ®Google Scholar
• KwokCSLokeYKMeta-analysis: effects of proton pump inhibitors on cardiovascular events and mortality in patients receiving clopidogrelAliment Pharmacol Ther201031881082320102352
   PubMed Web of Science ®Google Scholar
• BedsonJWhitehurstTLewisMCroftPFactors affecting over-the-counter use of aspirin in the secondary prophylaxis of cardiovascular diseaseBr J Gen Pract2001514731001100311766849
   PubMed Web of Science ®Google Scholar
• CampbellNCThainJDeansHGRitchieLDRawlesJMSecondary prevention in coronary heart disease: baseline survey of provision in general practiceBMJ19983167142143014349572757
   PubMed Web of Science ®Google Scholar
• HopperSPierceMAspirin after myocardial infarction: the importance of over-the-counter useFam Pract199815Suppl 1S10S139613460
   PubMed Web of Science ®Google Scholar
• HaynesRBYaoXDeganiAKripalaniSGargAMcDonaldHPInterventions to enhance medication adherenceCochrane Database Syst Rev20054CD00001116235271
   PubMed Web of Science ®Google Scholar